Search research articles
Contact Us
Filters
Showing results (51-60 of 180) with videos related to
Page
of 18
Sort By:
Developmental Cell
|
May 18, 2016
PRICKLE1 Contributes to Cancer Cell Dissemination through Its Interaction with mTORC2
Avais M Daulat, François Bertucci, Stéphane Audebert, et al.
Anticancer Research
|
November 1, 2007
Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers
François Bertucci, Cécile Pages, Pascal Finetti, et al.
Stem Cells (Dayton, Ohio)
|
July 30, 2014
Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome
Rita El Helou, Julien Wicinski, Arnaud Guille, et al.
Cancers
|
March 10, 2022
CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response
Alexandre de Nonneville, Pascal Finetti, Maelle Picard, et al.
Molecular and Clinical Oncology
|
January 26, 2019
Inflammatory breast cancer in 210 patients: A retrospective study on epidemiological, anatomo-clinical features and therapeutic results
Maroua Manai, Pascal Finetti, Nesrine Mejri, et al.
Oncotarget
|
September 11, 2015
H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b
Constance Vennin, Nathalie Spruyt, Fatima Dahmani, et al.
Blood
|
March 5, 2016
PLZF mutation alters mouse hematopoietic stem cell function and cell cycle progression
Christelle Vincent-Fabert, Nadine Platet, Amelle Vandevelde, et al.
Journal of Cell Science
|
August 16, 2022
The serine/threonine kinase MINK1 directly regulates the function of promigratory proteins
Avais M Daulat, Mônica S Wagner, Stéphane Audebert, et al.
British Journal of Cancer
|
April 12, 2019
ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
Avais M Daulat, Pascal Finetti, Diego Revinski, et al.
Journal of Translational Medicine
|
October 11, 2022
CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response
Laurys Boudin, A de Nonneville, Pascal Finetti, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 180) with videos related to
Sort By:
Page
of 18
Developmental Cell
|
May 18, 2016
PRICKLE1 Contributes to Cancer Cell Dissemination through Its Interaction with mTORC2
Avais M Daulat, François Bertucci, Stéphane Audebert, et al.
Anticancer Research
|
November 1, 2007
Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers
François Bertucci, Cécile Pages, Pascal Finetti, et al.
Stem Cells (Dayton, Ohio)
|
July 30, 2014
Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome
Rita El Helou, Julien Wicinski, Arnaud Guille, et al.
Cancers
|
March 10, 2022
CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response
Alexandre de Nonneville, Pascal Finetti, Maelle Picard, et al.
Molecular and Clinical Oncology
|
January 26, 2019
Inflammatory breast cancer in 210 patients: A retrospective study on epidemiological, anatomo-clinical features and therapeutic results
Maroua Manai, Pascal Finetti, Nesrine Mejri, et al.
Oncotarget
|
September 11, 2015
H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b
Constance Vennin, Nathalie Spruyt, Fatima Dahmani, et al.
Blood
|
March 5, 2016
PLZF mutation alters mouse hematopoietic stem cell function and cell cycle progression
Christelle Vincent-Fabert, Nadine Platet, Amelle Vandevelde, et al.
Journal of Cell Science
|
August 16, 2022
The serine/threonine kinase MINK1 directly regulates the function of promigratory proteins
Avais M Daulat, Mônica S Wagner, Stéphane Audebert, et al.
British Journal of Cancer
|
April 12, 2019
ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
Avais M Daulat, Pascal Finetti, Diego Revinski, et al.
Journal of Translational Medicine
|
October 11, 2022
CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response
Laurys Boudin, A de Nonneville, Pascal Finetti, et al.
Page
of 18